{"id":"W4411330596","doi":"10.1212/wnl.0000000000213885","title":"2025 Late-Breaking Science Abstracts","year":2025,"lang":"en","type":"article","venue":"Neurology","topic":"Academic Publishing and Open Access","field":"Decision Sciences","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Chugai Pharmaceutical; Seqirus; Italfarmaco; Ipsen; Mitsubishi Tanabe Pharma Corporation; Genentech; Horizon Therapeutics; Audentes Therapeutics; EMD Serono; Sarepta Therapeutics; AveXis; Japan Blood Products Organization; FibroGen; Cytokinetics; Myasthenia Gravis Foundation of America; ALS Society of Canada; Acorda Therapeutics; H. Lundbeck A/S; Sunovion; TG Therapeutics; National Institutes of Health; Regeneron Pharmaceuticals; Muscular Dystrophy Association; Neurocrine Biosciences; Alexion Pharmaceuticals; Massachusetts General Hospital; Teva Pharmaceutical Industries; Allergan; Parent Project Muscular Dystrophy; Pfizer; Biogen; Centers for Disease Control and Prevention; PTC Therapeutics; Sanofi; US WorldMeds; CSL Behring; Eli Lilly and Company; UCB Pharma; Argenx; Michael J. Fox Foundation for Parkinson's Research; Amgen","keywords":"Medicine; Psychology","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001377324,0.001133096,0.0009571047,0.001568049,0.0008575089,0.005229879,0.001050437,0.002637828,0.5095374],"category_scores_gemma":[0.002672073,0.0003406782,0.0006827888,0.001347441,0.0003562749,0.00136177,0.001418944,0.002365127,0.3444057],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001608242,"about_ca_system_score_gemma":0.002345934,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007744879,"about_ca_topic_score_gemma":0.001510279,"domain_scores_codex":[0.9993205,0.00008371896,0.00005856359,0.0001082879,0.0003233613,0.0001055263],"domain_scores_gemma":[0.9974166,0.0001900186,0.0001979446,0.0001212948,0.001201915,0.0008720524],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0004631481,0.0001255633,0.0002947586,0.0007844542,0.00004401453,0.0001141531,0.0000113403,0.00004627796,0.001606336,0.001036991,0.8564439,0.139029],"study_design_scores_gemma":[0.00008122134,0.00007793881,0.0005570428,0.0001705083,0.00001662632,0.00005040296,0.00001120801,0.00004161659,0.0002630643,0.0003704602,0.9983559,0.000003855791],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"other","genre_gemma":"other","genre_scores_codex":[0.00376619,0.05191413,0.002102796,0.04378449,0.1202552,0.0009890253,0.01782128,0.00166445,0.7577024],"genre_scores_gemma":[0.008557414,0.02082784,0.0008448833,0.0152358,0.03029615,0.0003061601,0.0122884,0.0003849384,0.9112585],"genre_candidate":"other","genre_consensus":"other","teacher_disagreement_score":0.5095374,"threshold_uncertainty_score":0.6995854,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0680816926358673,"score_gpt":0.419303531709246,"score_spread":0.3512218390733787,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}